News

DeOvo™ demonstrates safety and clear efficacy against head lice and their eggs from one single application and is now positioned to accelerate into Phase 3.

Sydney, December 16, 2011 – Smart Sparrow Pty Ltd, have today announced it has secured a significant round of venture capital investment to accelerate the commercialisation of its proprietary online Intelligent Tutoring e-learning platform.

A PLAN to deliver vaccines to millions of the world's poor through biomedical patches the size of postage stamps was named the overall winner at The Australian Innovation Challenge awards in Brisbane.

“Hatchtech Pty Ltd is pleased to announce the appointment of Mr. Timothy Waugh as Chief Executive Officer.”

“Barminco plans to develop a diesel particulate management plan.”

The state has also injected another $3 million into supporting digital content projects.

Tears in the doctor's surgery at immunisation time could be a thing of the past thanks to the development of a needle-free vaccination that can be mailed to your home.

MELBOURNE, Victoria: Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.

Getting your shots at the doctor could be a pain-free experience thanks to the commercialisation of a needle-free vaccination called NanopatchTM – made possible by the Australian Government’s Innovation Investment Fund.